Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Henry

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|January 23, 2013
A randomized, double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus coformulated emtricitabine and tenofovir DF for initial treatment of HIV-1 infection: analysis of week 96 resultsJürgen K Rockstroh, Edwin DeJesus, Keith Henry, et al.
Sexually Transmitted Diseases|December 21, 2011
Ongoing sexually transmitted disease acquisition and risk-taking behavior among US HIV-infected patients in primary care: implications for prevention interventionsKenneth H Mayer, Timothy Bush, Keith Henry, et al.
Lancet (London, England)|July 4, 2012
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trialEdwin DeJesus, Jürgen K Rockstroh, Keith Henry, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2003
Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials GroupMichael P Dubé, James H Stein, Judith A Aberg, et al.
Journal of Virology|April 13, 2018
HIV Protease-Generated Casp8p41, When Bound and Inactivated by Bcl2, Is Degraded by the ProteasomeSekar Natesampillai, Nathan W Cummins, Zilin Nie, et al.
AIDS (London, England)|December 28, 2013
Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohortJason V Baker, Katherine Huppler Hullsiek, Amrit Singh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 2006
A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102Keith Henry, David Katzenstein, Deborah Weng Cherng, et al.
The Journal of Biological Chemistry|September 3, 2014
Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding siteRejwi Acharya Dahal, Akula Bala Pramod, Babita Sharma, et al.
The Journal of Infectious Diseases|February 17, 2018
Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types Covered by Current HPV Vaccines Among HIV-Infected Women in the SUN StudyErna Milunka Kojic, Lois Conley, Tim Bush, et al.
AIDS Patient Care and Stds|December 4, 2012
Sadness in the SUN: using computerized screening to analyze correlates of depression and adherence in HIV-infected adults in the United StatesEllen M Tedaldi, Mary van den Berg-Wolf, James Richardson, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Journal of Acquired Immune Deficiency Syndromes (1999)|January 23, 2013
A randomized, double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus coformulated emtricitabine and tenofovir DF for initial treatment of HIV-1 infection: analysis of week 96 resultsJürgen K Rockstroh, Edwin DeJesus, Keith Henry, et al.
Sexually Transmitted Diseases|December 21, 2011
Ongoing sexually transmitted disease acquisition and risk-taking behavior among US HIV-infected patients in primary care: implications for prevention interventionsKenneth H Mayer, Timothy Bush, Keith Henry, et al.
Lancet (London, England)|July 4, 2012
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trialEdwin DeJesus, Jürgen K Rockstroh, Keith Henry, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2003
Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials GroupMichael P Dubé, James H Stein, Judith A Aberg, et al.
Journal of Virology|April 13, 2018
HIV Protease-Generated Casp8p41, When Bound and Inactivated by Bcl2, Is Degraded by the ProteasomeSekar Natesampillai, Nathan W Cummins, Zilin Nie, et al.
AIDS (London, England)|December 28, 2013
Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohortJason V Baker, Katherine Huppler Hullsiek, Amrit Singh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 2006
A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102Keith Henry, David Katzenstein, Deborah Weng Cherng, et al.
The Journal of Biological Chemistry|September 3, 2014
Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding siteRejwi Acharya Dahal, Akula Bala Pramod, Babita Sharma, et al.
The Journal of Infectious Diseases|February 17, 2018
Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types Covered by Current HPV Vaccines Among HIV-Infected Women in the SUN StudyErna Milunka Kojic, Lois Conley, Tim Bush, et al.
AIDS Patient Care and Stds|December 4, 2012
Sadness in the SUN: using computerized screening to analyze correlates of depression and adherence in HIV-infected adults in the United StatesEllen M Tedaldi, Mary van den Berg-Wolf, James Richardson, et al.
Pageof 14